Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters

Virology

Volumn 244, Issue 2, 1998, Pages 504-512

  Beld, Marcel ^a   Penning, Maarten ^a   Lukashov, Vladimir ^a   McMorrow, Martin ^b   Roos, Marijke ^c   Pakker, Nadine ^c   Van Den Hoek, Anneke ^d   Goudsmit, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Chiron Biopharmaceuticals Europe   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMORBIDITY; CROSS REACTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032503230     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9130     Document Type: Article

References (31)

1. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E., Meeks E. L., Beach M. J. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties chronic non-A, non-B hepatitis study team. N. Engl. J. Med. 327:1992;1899-1905.
2. Beld M., Penning M., McMorrow M., Gorgels J., van den Hock A., Goudsmit J. Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serumalanine aminotransferase levels. J. Clin. Microbiol. 23:1998;872-877.
3. Botarelli P., Brunetto M. R., Minutello M. A., Calvo P., Unutmaz D., Weiner A. J., Choo Q. L., Shuster J. R., Kuo G., Bonino F., Houghton M., Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
4. Cao Y., Dieterich D., Thomas P. A., Huang Y., Mirabile M., Ho D. D. Identification and quantification of HIV-1 in the liver of patients with AIDS. AIDS. 6:1992;65-70.
5. Chambost H., Gerolami V., Halfon P., Thuret I., Michel G., Sicardi F., Rousseau S., Perrimond H., Cartouzou G. Persistent hepatitis C virus RNA replication in haemophiliacs: Role of co-infection with human immunodeficiency virus. Br. J. Haematol. 91:1995;703-707.
6. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
7. Cribier B., Rey D., Schmitt C., Lang J. M., Kirn A., Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS. 9:1995;1131-1136.
8. De Mitri M. S., Poussin K., Baccarini P., Pontisso P., D'Errico A., Simon N., Grigioni W., Alberti A., Beaugrand M., Pisi E., Brechot C., Paterlini P. HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
9. Diepolder H. M., Zachoval R., Hoffmann R. M., Wierenga E. A., Santantonio T., Jung M. C., Eichenlaub D., Pape G. R. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
10. Esteban R. Epidemiology of hepatitis C virus infection. J. Hepatol. 17:1993;S67-71.
11. Eyster M. E., Diamondstone L. S., Lien J. M., Ehmann W. C., Quan S., Goedert J. J. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J. Acquir. Imm. Def. Syndr. 6:1993;602-610.
12. Eyster M. E., Fried M. W., Di Bisceglie A. M., Goedert J. J. Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood. 84:1994;1020-1023.
13. Ferbeyre G., Bourdeau V., Cededergren R. Does HIV tat protein also regulate genes of other viruses present in HIV infection. Trends Biochem. Sci. 22:1997;155-156.
14. Gemen van B., Beuningen van R., Nabbe A., Strijp van D., Jurriaans S., Lens P., Kievits T. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent. J. Virol. Methods. 49:1994;157-168.
15. Ghany M. G., Leissinger C., Lagier R., Sanchez-Pescador R., Lok A. S. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig. Dis. Sci. 41:1996;1265-1272.
16. Housset C., Lamas E., Courgnaud V., Boucher O., Girard P. M., Marche C., Brechot C. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J. Hepatol. 19:1993;252-258.
17. Hufert F. T., Schmitz J., Schreiber M., Schmitz H., Racz P., Laer von D. D. Human Kupfer cells infected with HIV-1 in vivo. J. Acquir. Immune. Defic. Syndr. 6:1993;772-777.
18. Jurriaans S., Weverling G. J., Goudsmit J., Boogaard J., Brok M., Strijp van D., Lange J. M. A., Koot M., Gemen van B. Distinct changes in HIV-1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS. AIDS Res. Hum. Retroviruses. 11:1995;473-479.
19. Kievits T., Gemen van B., Strijp van D., Schukkink R., Dircks M., Adriaanse H., Malek L., Sooknanan R., Lens P. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods. 35:1991;273-286.
20. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., Rumi M. G., Houghton M., Fiaccadori F., Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of anti-viral cell-mediated immune response. J. Clin. Invest. 98:1996;706-714.
21. Rehermann B., Chang K.-M., McHutchison J. G., Kokka R., Houghton M., Chisari F. V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1996;1432-1440.
22. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q. L., Hughton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
23. Schellekens P. T. A., Roos M. T. L., de Wolf F., Lange J. M. A., Miedema F. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men. J. Clin. Immunol. 10:1990;121-127.
24. Sherman K. E., O'Brien J., Gutierrez A. G., Harrison S., Urdea M., Neuwald P., Wilber J. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J. Clin. Microbiol. 31:1993;2679-2682.
25. Telfer P. T., Brown D., Devereux H., Lee C. A., Dusheiko G. M. HCV RNA levels and HIV infection: Evidence for a viral interaction in haemophilic patients. Br. J. Haematol. 88:1994;397-399.
26. Thomas D. L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., Nelson K. E. Correlates of hepatitis C virus infections among injecting drug users. Medicine. 74:1995;212-220.
27. Thomas D. L., Shih J. W., Alter H. J., Vlahov D., Cohn S., Hoover D. R., Cheung L., Nelson K. E. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Inf. Dis. 174:1996;690-695.
28. van den Hoek J. A. R., Coutinho R. A., van Haastrecht H. J., van Zadelhoff A. W., Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS. 2:1988;55-60.
29. van den Hoek J. A. R., Goudsmit J., de Wolf F., Coutinho R. A. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J. Inf. Dis. 162:1990;823-826.
30. Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 335:1988;606-611.
31. Watson H. G., Ludlam C. A., Rebus S., Zhang L. Q., Peutherer J. F., Simmonds P. Use of several second-generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus-inactivated factor VIII and IX concentrates. Br. J. Haematol. 80:1992;514-518.